BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28

• Business

  Vanda Pharma Reports Fourth Quarter 2017 and Full Year 2017 Financial Results

  Vanda Pharma today announced financial and operational results for the fourth quarter and full year ended December 31, 2017.

  February 14, 2018

   · 

  23 min read
• Bio NC

  Veloxis Secures $60M in Debt Financing

  Veloxis today announced that it has obtained $60M of capital from funds managed by Athyrium.

  February 14, 2018

   · 

  3 min read
• Business

  Agilent Technologies Reports First-Quarter Fiscal Year 2018 Financial Results

  Agilent Technologies today reported revenue of $1.21 billion for the first-quarter ended January 31, 2018, up 14 percent year over year.

  February 14, 2018

   · 

  21 min read
• 

  Business

  LivaNova Takes Out TandemLife in $250M Deal

  Company will add advanced cardiopulmonary temporary support solutions to its portfolio.

  February 14, 2018

   · 

  6 min read
• Deals

  Exactech Announces Completion of Merger with TPG Capital

  Exactech announce the successful completion of the previously announced merger agreement with TPG Capital, pursuant to which TPG has acquired all of the issued and outstanding common stock of Exactech.

  February 14, 2018

   · 

  4 min read
• Drug Development

  The New England Journal of Medicine Publishes Biogen’s SPINRAZA (nusinersen) Phase III Study Results in Individuals with Later-Onset Spinal Muscular Atrophy

  Data from the other endpoints analyzed, including attainment of new motor milestones and upper limb motor function, were consistently in favor of individuals who received treatment and were considered clinically significant.

  February 14, 2018

   · 

  15 min read
• Business

  DelMar Pharma Announces Second Quarter Fiscal Year 2018 Financial Results

  DelMar Pharma announced its financial results for the second quarter ended December 31, 2017.

  February 14, 2018

   · 

  12 min read
• 

  Business

  Go Big or Go Home: Bristol-Myers Bets $3.6B on Nektar’s Early-Stage Cancer Prospect

  Rumors of Nektar Therapeutics being up for sale may have been premature.

  February 14, 2018

   · 

  3 min read

   · 

  Alex Keown
• 

  Policy

  Merck Chemist Arrested for Stealing Deadly Chemical

  The 60-year-old chemist has been charged with stealing 219.79 grams of potassium cyanide from a Merck facility in Pennsylvania.

  February 14, 2018

   · 

  2 min read

   · 

  Alex Keown
• 

  Policy

  FDA Berates Bayer for Inadequate Cleaning, QC Questions at HQ

  The company is addressing the FDA’s complaints regarding manufacturing practices, which stem from a routine inspection in January,

  February 14, 2018

   · 

  1 min read